ABOUT THE DR.TALK TO THE DR.HEALTHY LINKSWHAT'S NEWHOMEWHAT'S NEW
Ask The Doctor.com
ABOUT THE DR./ TALK TO THE DR.
HEALTHY LINKS/ WHAT'S NEW

 

WHAT'S NEW

 

ECP: INTRODUCTION
ECP: TREATMENT PROTOCOL
ECP: THE CONCEPT
ECP: CLINICAL RESPONSE
ECP: PATIENT TESTIMONIALS

ECP: THE CONCEPT

More than 40 years ago, Kantrowitz and Kantrowitz first described the principle of "phase shift diastolic augmentation". Several groups of physicians related this principle to the oxygen consumption difference between flow work and pressure work by the heart (Birtwell et al. 1976).

Harken developed direct counterpulsation techniques at Harvard in the late 1950's (Harken 1976). A femoral cutdown and external pulse actuation was used to withdraw and return blood to the arterial system (Birtwell et al. 1970). In the early 1960's, animal studies demonstrated the potential efficacy of counterpulsation as a treatment following coronary occlusion (Jacobey 1971).

The concept of counterpulsation is based on the response of the left ventricle to reduced arterial pressure during the systolic period. A number of investigators have demonstrated good correlation between oxygen consumption of the left ventricle and pressure time (Birtwell et al. 1976). Additional studies concluded a correlation with maximal cardiac oxygen consumption under constant cardiac contractility and ventricular volume (Langou et al. 1977).

Studies of the hemodynamic effects of counterpulsation reveal several factors that give this therapy the potential to assist patients with low cardiac output syndromes (Birtwell et al. 1976):

  • Coronary flow increases with the diastolic pressure since coronary vascular resistance is minimal during cardiac diastole.
  • Counterpulsation increases stroke volume per unit work and thus the efficiency of the left ventricle. The left ventricular pressure and PTM is reduced, or the cardiac output is increased, or both.
  • Diastolic perfusion pressure and the ratio of mean diastolic pressure to mean systolic pressure are increased.
  • Coronary collateral flow to ischemic regions of the myocardium is increased.
Diastolic Augmentation
The original purpose for ECP was to reduce myocardial oxygen demand. This remains an important result of ECP, however as the device has been actively applied to chronic angina patients, diastolic augmentation to increase coronary perfusion pressure and thus coronary blood flow, has become the primary objective.

In 1996 the effect of external counterpulsation treatment on exercise hemodynamics and myocardial stress perfusion in 27 patients was studied. 81% of patients improved their exercise tolerance after treatment. Post treatment, maximal exercise heart rate and blood pressure, while demonstrating a linear relation with exercise duration, did not increase significantly despite the increased exercise duration. This suggests that the increase in exercise duration after treatment is due to both improved myocardial perfusion and altered exercise hemodynamics. External counterpulsation appears to exert a "training effect", decreasing peripheral vascular resistance and the heart rate response to exercise (Lawson et al. 1996).

Hemodynamics - When the rapidly increasing pressure within the left ventricle, caused by contraction of the myocardium, exceeds the pressure within the aorta, the aortic valve opens and the ventricle ejects its volume of blood. Both cardiac work and myocardial oxygen consumption relate directly to the aortic pressure which the left ventricle must overcome during ejection. Rapid ejection of blood from the left ventricle causes the elastic walls of the aorta to expand to handle the blood volume and creates a peak systolic pressure. The aortic valve will close when the left ventricular pressure is less than the aortic pressure. If the heart muscle is deprived of oxygen for even a few minutes, its pumping ability diminishes and injury to the heart muscle may result. As a protective mechanism, the heart has its own ability to regulate blood flow by autoregulation. Autoregulation allows the heart to increase its blood flow through enlargement of blood vessels, or decrease its blood flow by constriction of blood vessels. However, the heart can only increase its blood flow by autoregulation to a certain point. Once this point is reached, the heart requires mechanical assistance to increase the supply of oxygenated blood.

External counterpulsation (ECP) provides assistance to the heart and other muscle/tissue by "diastolic augmentation". Diastolic augmentation is the elevation of blood pressure during diastole. ECP produces diastolic augmentation during diastole by sequentially inflating cuffs positioned on the patient's calves, thighs and buttocks. Counterpulsation produces an increase in pressure within the aorta, which increases perfusion both within the heart and systemically. As a result, external counterpulsation may be beneficial in several ways. Myocardial and other muscle/tissue perfusion may be increased by the augmented diastolic pressure. Cardiac efficiency may be improved by counterpulsation due to the pressure drop during systole. Peripheral perfusion may also be enhanced by the rise in mean systemic perfusion pressure. Near the end of diastole, before the ventricles contract in systole, ECP deflates the cuffs causing a reduction in intra-aortic volume and pressure. This can reduce the afterload or resistance to pumping blood out of the ventricles. Because approximately 80-90% of the oxygen required by the heart is used during contraction to pump blood out of the ventricles, counterpulsation may also be effective in reducing the heart's oxygen requirement.

Arterial System Effect - The pressure pulse applied to the patient's torso by ECP drives blood from the arterial system back into the aorta and arteries of the upper body. The propagated pressure front causes an increase in aortic pressure, the "augmented diastolic pressure" often exceeding the normal peak systolic value. Relaxation of the air cuff pressure pulse during cardiac systole lowers the resistance to blood flow in the patient's buttocks and legs, reducing the back pressure on the heart as it ejects its bolus of blood. The combination of increased coronary flow and reduction of cardiac work (afterload) by counterpulsation improves cardiac function.

Venous System Effect

Venous System Effect - During counterpulsation, cardiac preload is not significantly increased by positive pulsatile pressure to the venous system of the lower extremities. Blood in the venous bed is quickly displaced into the low pressure, high volume venous pool. Retrograde flow is prevented by both the low central venous pressure and valves in the major peripheral veins when the pressure is released. This means venous pressure remains near normal.

ECP Evolves
The early external counterpulsation devices were hydraulically driven, large and only moderately effective. Several scientists in the United States began developing sequential, pneumatic devices as well as Zheng and colleagues in China. They all found that a newly designed sequenced pneumatic system produced a more effective increase in diastolic pressures. It is these, and other devoted physicians and scientists, who have more recently shown that patients with chronic angina have had complete resolution of ischemic defects (67%) and reduction in the area of ischemia (11%) (Lawson et al. 1992). A 3-year follow-up on patients who improved from counterpulsation therapy resulted in 80% remaining pain free. (Lawson et al. 1995).

continue >   < back

NAVIGATIONECP